Radiofrequency Ablation of Hepatocellular Carcinoma: Correlation Between Local Tumor Progression After Ablation and Ablative MarginTakahide Nakazawa, Katsunori Saigenji, Shigehiro Kokubu et al.|American Journal of Roentgenology|2007Cited by 345
Overall survival in response to sorafenib versus radiotherapy in unresectable hepatocellular carcinoma with major portal vein tumor thrombosis: propensity score analysisTakahide Nakazawa, Wasaburo Koizumi, Hisashi Hidaka et al.|BMC Gastroenterology|2014Cited by 132
Early increase in α-fetoprotein for predicting unfavorable clinical outcomes in patients with advanced hepatocellular carcinoma treated with sorafenibTakahide Nakazawa, Wasaburo Koizumi, Hisashi Hidaka et al.|European Journal of Gastroenterology & Hepatology|2013Cited by 81
Intrahepatic distant recurrence after radiofrequency ablation for a single small hepatocellular carcinoma: Risk factors and patternsYusuke Okuwaki, Katsunori Saigenji, Takahide Nakazawa et al.|Journal of Gastroenterology|2008Cited by 79
Higher discontinuation and lower survival rates are likely in elderly Japanese patients with advanced hepatocellular carcinoma receiving sorafenibManabu Morimoto, Katsuaki Tanaka, Kazushi Numata et al.|Hepatology Research|2011Cited by 77